Fleming John Turman 4

What Happened

• Fleming John Turman, a director of USANA Health Sciences, received a grant of 6,527 restricted stock units (RSUs) on May 7, 2026. The award was reported as an acquisition (code A) at $0.00 per unit (no cash paid at grant). These RSUs are derivative awards that represent the contingent right to receive one share of USNA common stock per unit upon vesting.

Key Details

• Transaction date: May 7, 2026; Form filed May 11, 2026 (appears to be filed after the typical 2-business-day Form 4 deadline).
• Security/amount: 6,527 RSUs granted (derivative), price reported $0.00.
• Shares owned after transaction: Not specified in the provided filing details.
• Footnotes: F1 — each RSU converts to one share if and when vested. F2 — RSUs vest 25% on each of these dates: July 23, 2026; Oct 22, 2026; Jan 21, 2027; Apr 22, 2027.
• Transaction code: A = Award/Grant.

Context

• RSU grants to directors are typically compensation/retention awards rather than open-market purchases or sales; they do not by themselves signal a buy or sell decision until (and unless) shares are sold after vesting.
• Because the filing appears to have been submitted four days after the grant, it may have missed the usual 2-business-day Form 4 reporting window; investors tracking insider timing should note the later filing.